Press Release

Endocrine Society issues statement on health insurance policy announcements

Washington, DC October 16, 2017

Last week President Trump made a number of announcements related to health insurance policy. First, he signed an executive order that seeks to increase competition by facilitating access to association health plans, short-term limited duration insurance products, and health reimbursement arrangements. Nothing is changing immediately; rather, the president has directed several government agencies to draft regulations to implement new policies over the next 60 to 120 days. Experts disagree about whether and how these policies can be implemented via regulation, so it is not yet clear what the effects of these new policies may be. Since association health plans and short-term insurance products do not need to follow a number of ACA patient protections, they could appeal to younger, healthier people who seek skimpier, less expensive coverage. This would raise costs for many of the people our members treat who need comprehensive coverage.

President Trump also announced that the White House will discontinue making cost-sharing reduction (CSR) payments to health insurance companies that subsidize out-of-pocket costs for low-income people. Plans in a number of states have increased premiums in anticipation of the CSR payments stopping, but the biggest risk for consumers is that insurance companies will drop out of marketplaces for next year. Already 15 states and the District of Columbia have filed lawsuits to ensure that the payments continue, so it is also unclear whether this change will take effect.

The combined effect of these policies adds further uncertainty to the health insurance market, where insurers and individuals are preparing for the start of open enrollment on November 1. These actions also add new pressure for Congress to pass bipartisan legislation to stabilize health insurance markets.

The Society will be closely monitoring regulations to implement the executive order and potential legislation in Congress regarding insurance markets. We will continue to advocate for access to comprehensive, quality insurance for patients and will provide an update as more information on the impact of these changes becomes available.

About the Endocrine Society
Endocrinologists are at the core of solving the most pressing health problems of our time, including diabetes, obesity, infertility, bone health, and hormone-related cancers. The Endocrine Society is the largest global organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

With more than 18,000 members in 133 countries, the Society serves as the voice of the endocrine field. Through its renowned journals and ENDO, the world's largest endocrine meeting, the Society accelerates hormone research, advances clinical excellence in endocrinology, and advocates for evidence-based policies on behalf of the global endocrine community. To learn more, visit our online newsroom

Media Contacts

Colleen Williams Associate Director, Communications and Media Relations Phone: (202)-971-3611 [email protected]

Jenni Glenn Gingery Director, Communications and Media Relations Phone: (202)-971-3655 [email protected]

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.